Home › High Blood Pressure › Tennessee › Memphis
High Blood Pressure clinical trials in Memphis, TN
4 studies for High Blood Pressure are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Olive Branch Family Medical Center, Olive Branch · 18 mi away
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Olive Branch · 18 mi away
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
RecruitingPhase 2
- Clinical Neuroscience Solutions Inc, Memphis
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Recruiting
- University of Tennessee Health Science Center/Regional One Health, Memphis
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Birmingham, AL11 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.